drugset / Trial / NCT02302209

Dyad Oxytocin Study (DOS)

NCT02302209

Phase 1 Completed 104 enrolled University of California, San Francisco
RandomizedCrossoverDouble-blindOther

Summary

The purpose of the investigators proposed study is twofold: 1) To investigate the role of the affiliative neuropeptide oxytocin in unhealthy interactions in families of patients with schizophrenia and families of patients with autism spectrum disorder, and 2) to investigate whether manipulation of this oxytocinergic system positively influences these family interactions.

Timeline

Start
2011-04
Primary completion
2017-10
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 40 iu Intranasal